Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/24/1989 | DE3737367A1 Vascular anticoagulant proteins, DNA which encode the latter, process for their preparation and their use |
05/24/1989 | CN1033074A Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes |
05/24/1989 | CN1033072A Recombinant dna-derived bordetella toxin subvnit analogs |
05/24/1989 | CN1033071A Monoclonal antibody specific to hiv antigens |
05/24/1989 | CN1033070A Modified plasminogen activators |
05/23/1989 | US4833332 Scanning fluorescent detection system |
05/23/1989 | US4833239 Method for the isolation and purification of DNA molecules |
05/23/1989 | US4833086 Plasmids, pollution control, culture of alcaligenes, ethylene dchloride |
05/23/1989 | US4833085 Monoclonal antibody specific for human colon fibroblast-derived t-PA |
05/23/1989 | US4833080 Regulation of eucaryotic gene expression |
05/23/1989 | US4833071 Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor |
05/23/1989 | US4832959 Preparation of polypeptides having human γ-interferon activity |
05/23/1989 | CA1254527A1 Expression vectors for enhanced production of polypeptides, plasmids containing the vectors, hosts containing the plasmids, products manufactured thereby and related methods |
05/23/1989 | CA1254526A1 Enhancement of nucleic acid hybridization by anionic polymers |
05/18/1989 | WO1989004491A1 Urinary assay for measuring bone resorption |
05/18/1989 | WO1989004486A1 Diagnostic methods and systems for quantifying apo ai |
05/18/1989 | WO1989004376A1 Monoclonal antibody specific to hiv antigens |
05/18/1989 | WO1989004371A1 Plants genetically enhanced for disease resistance |
05/18/1989 | WO1989004370A1 Human monoclonal anti-hiv-i-antibodies |
05/18/1989 | WO1989004368A1 Novel human tissue-type plasminogen activator variant |
05/18/1989 | WO1989004367A1 Method of purifying recombinant proteins from corresponding host cell proteins |
05/18/1989 | WO1989004365A1 Microorganism having low acetate forming capability and its application |
05/18/1989 | WO1989004327A1 Human monoclonal antibody against aspergilli |
05/18/1989 | WO1989004326A1 Alveolar surfactant proteins |
05/18/1989 | WO1989004320A1 PRODUCTION OF ANIMAL LYSOZYME c VIA SECRETION FROM PICHIA PASTORIS AND COMPOSITION THEREFOR |
05/18/1989 | WO1989004209A1 Emulsifiers |
05/18/1989 | WO1989004175A1 Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes |
05/18/1989 | WO1989004174A1 Anti-c3bi receptor (cr3) antibodies and therapeutic composition |
05/18/1989 | WO1989003846A3 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
05/17/1989 | EP0316306A2 Monoclonal antibodies special for HB A1c |
05/17/1989 | EP0316229A1 Microorganism having low acetate forming capability, and process for production of useful substrate using same |
05/17/1989 | EP0316170A2 Method for the identification of antigens expressed in vivo, diagnostic assays therefor and vaccines containing them |
05/17/1989 | EP0316115A2 Novel voctors and expression sequences for production of polypeptides |
05/17/1989 | EP0316068A1 Modified low molecular weight plasminogen activator and method of preparation |
05/17/1989 | EP0316018A2 Modification of DNA sequences |
05/17/1989 | EP0316016A2 Modified oligonucleotides |
05/17/1989 | EP0315949A2 A method for microbiological reaction |
05/17/1989 | EP0315944A2 Controlled growth rate fermentation |
05/17/1989 | EP0315782A2 Method for the production of proteins |
05/17/1989 | EP0315683A1 Dna sequences, recombinant dna molecules and processes for producing lymphocyte function associated antigen-3 |
05/17/1989 | EP0315650A1 Purification of recombinant interleukin-1. |
05/16/1989 | US4831124 Recombinant cDNA construction method and hybrid nucleotides useful in cloning |
05/16/1989 | US4831120 Method for recovering a purified animal growth hormone or polypeptide analog thereof from a bacterial cell |
05/16/1989 | US4830969 Process for the rapid and simple isolation of nucleic acids |
05/16/1989 | US4830965 Dna sequence contains endonuclease recognition sites and base pair attachment sites for mu bacteriophage genome |
05/16/1989 | US4830962 Expression vectors encoding for a dt-a fragment which use dna control sequences not native to the coding sequences but compatible to the host |
05/16/1989 | EP0275298A4 Dmd probes. |
05/16/1989 | EP0228452A4 Protein purification. |
05/16/1989 | CA1254161A1 Herpes virus specific immunological materials and methods |
05/16/1989 | CA1254114A1 Displacement polynucleotide assay employing recombination protein and diagnostic kit |
05/11/1989 | EP0217822A4 Human metallothionein-ii promoter in mammalian expression system. |
05/10/1989 | EP0315456A2 Polysaccharide-modified immunoglobulins having reduced immunogenic potential or improved pharmacokinetics |
05/10/1989 | EP0315254A1 Protein 7B2, recombinant DNA, cDNA and mRNA, and a method of detecting the mRNA |
05/10/1989 | EP0315118A2 DNA coding for endothelin and use thereof |
05/10/1989 | EP0315085A2 Recombinant histidine-rich protein from Plasmodium falciparum, its synthesis and use |
05/10/1989 | EP0315081A2 Anti-coagulating protein PP4-x, its preparation and use |
05/10/1989 | EP0315062A2 Production of chimeric antibodies by homologous recombination |
05/10/1989 | EP0314862A1 Immunogenic conjugates comprising cyclosporins |
05/10/1989 | EP0314861A1 Labeled derivatives of cyclosporins |
05/10/1989 | EP0314744A1 Monokine dosing. |
05/10/1989 | CN1032816A Monoclonal antibodies against human interleukin-4 and hybridomas producing same |
05/09/1989 | US4828994 Genetic engineering, cloning vector, mutants, spores |
05/09/1989 | US4828990 Zinc or copper salt, polyethylenimine |
05/09/1989 | US4828988 Hybrid polypeptides comprising somatocrinine and alpha1 -antitrypsin, method for their production from bacterial clones and use thereof for the production of somatocrinine |
05/09/1989 | US4828987 Avian retrovirus-bovine growth hormone DNA |
05/09/1989 | US4828986 Elisa; monoclonal paratopic molecules secreted by hydbridomas to immunoreact |
05/09/1989 | US4828981 Competitive, homogeneous or heterogeneous |
05/09/1989 | US4828979 Biotinylated |
05/09/1989 | CA1253816A1 Monoclonal antibodies against alveolar surfactant protein |
05/09/1989 | CA1253777A1 Nucleic acid hybridization assay employing immobilized rna probes |
05/05/1989 | WO1989003996A1 Human gamma, delta t cell antigen receptor polypeptides and nucleic acids |
05/05/1989 | WO1989003993A1 Paired helical filament core and antibody thereto useful in diagnosing alzheimer's disease |
05/05/1989 | WO1989003887A1 A process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants |
05/05/1989 | WO1989003886A1 Expression systems for preparation of polypeptides in prokaryotic cells |
05/05/1989 | WO1989003884A1 Interleukin-7 |
05/05/1989 | WO1989003883A1 Enhancement of cell growth by expression of a cloned hemoglobin gene |
05/05/1989 | WO1989003882A1 Multiple promoter transforming retroviral vectors |
05/05/1989 | WO1989003881A1 Nonglycosylated analogs of human colony stimulating factors |
05/05/1989 | WO1989003880A1 A gene coding for glucuronide permease |
05/05/1989 | WO1989003879A1 Fowlpox virus promoters |
05/05/1989 | WO1989003878A1 Defective recombinant gene which can be activated by a transactivator |
05/05/1989 | WO1989003877A1 Integration and expression viral vectors |
05/05/1989 | WO1989003874A1 Novel polypeptide compounds |
05/05/1989 | WO1989003872A1 Generation of neural precursor cell lines |
05/05/1989 | WO1989003846A2 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
05/05/1989 | WO1989003845A1 Ps2 protein derivative |
05/03/1989 | EP0314569A1 Recombinant fowlpox virus, expression vectors for heterologous proteins, and vaccines for fowl derived from this virus |
05/03/1989 | EP0314534A1 Expression vector for proteins from the HIV-2 virus, one of the agents that cause AIDS |
05/03/1989 | EP0314500A2 Diagnostic probe for diabetes type 1 predisposition |
05/03/1989 | EP0314415A2 Interleukin-7 |
05/03/1989 | EP0314402A2 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
05/03/1989 | EP0314346A1 Method for producing the Afl II restriction endonuclease |
05/03/1989 | EP0314317A1 Adheson variants, nucleic acid encoding them and compositions comprising them |
05/03/1989 | EP0314294A2 Detection of listeria |
05/03/1989 | EP0314274A2 Improved promoter, vector having the improved promoter, plasmid having the vector, and E.coli transformed with the plasmid |
05/03/1989 | EP0314202A1 The isolation of mRNA |
05/03/1989 | EP0314184A1 Expression plasmids |
05/03/1989 | EP0314161A1 Human immunoglobulines produced by recombinant DNA techniques |
05/03/1989 | EP0314096A2 Methods of regulating protein glycosylation |
05/03/1989 | EP0314094A2 Recombinant lymphotoxin |